ANNISA RAHMAWATI, - (2024) ANALISIS EFEKTIVITAS BIAYA ANTIBIOTIK AMPISILIN DAN LEVOFLOKSASIN PADA PASIEN PNEUMONIA BALITA DI RSU PINDAD BANDUNG. Skripsi thesis, Sekolah Tinggi Farmasi Indonesia.
![[img]](http://repository.stfi.ac.id/style/images/fileicons/text.png) |
Text
S_PSSF_A201068_Tittle.pdf Download (419kB) |
|
Text
S_PSSF_A201068_Chapter1.pdf Restricted to Repository staff only Download (45kB) |
|
Text
S_PSSF_A201068_Chapter2.pdf Restricted to Repository staff only Download (180kB) |
|
Text
S_PSSF_A201068_Chapter3.pdf Restricted to Repository staff only Download (78kB) |
|
Text
S_PSSF_A201068_Chapter4.pdf Restricted to Repository staff only Download (69kB) |
|
Text
S_PSSF_A201068_Chapter5.pdf Restricted to Repository staff only Download (31kB) |
|
Text
S_PSSF_A201068_Appendix.pdf Restricted to Repository staff only Download (251kB) |
Abstract
Pneumonia adalah infeksi akut saluran pernapasan bagian bawah yang mengenai jaringan paru-paru (alveoli) yang disebabkan oleh berbagai mikroorganisme seperti virus, jamur dan bakteri. Penelitian ini bertujuan untuk mengetahui antibiotik mana yang lebih cost-effectiveness antara ampisilin dan levofloksasin untuk pasien pneumonia balita di RSU Pindad Bandung pada tahun 2023. Pada penelitian ini pengumpulan data dilakukan secara retrospektif dari rekam medis pasien pneumonia balita periode Januari – Desember 2023 yang mendapatkan terapi antibiotik dengan kelengkapan pembiayaan, antara lain biaya obat, biaya rawat inap, dan biaya laboratorium. Hasil menunjukan nilai Average cost effectiveness Ratio (ACER) pada antibiotik ampisilin yaitu sebesar Rp. 12.271 lebih rendah dibandingkan antibiotik levofloksasin yaitu sebesar Rp. 13.250. Antibiotik ampisilin lebih cost-effectiveness dibandingkan antibiotik levofloksasin. ----- Pneumonia is an acute infection of the lower respiratory tract that affects the lung tissue (alveoli) caused by various microorganisms such as viruses, fungi and bacteria. This study aims to determine which antibiotic is more cost-effective between ampicillin and levofloxacin for toddler pneumonia patients at RSU Pindad Bandung in 2023. In this study, data collection was carried out retrospectively from the medical records of toddler pneumonia patients from January to December 2023 who received antibiotic therapy with complete financing, including drug costs, hospitalization costs, and laboratory costs. The results showed the Average CostEffectiveness Ratio (ACER) value for ampicillin antibiotics, which was Rp. 12,271 lower than levofloxacin antibiotics, which was Rp. 13,250. Ampicillin antibiotics are more cost-effective than levofloxacin antibiotics.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Uncontrolled Keywords: | Pneumonia, Analisis Efektivitas Biaya, ACER. ---- Pneumonia, Cost Effectiveness Analysis, ACER |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
| Divisions: | Program Studi S1 Farmasi |
| Depositing User: | pustakawan - - |
| Date Deposited: | 12 Nov 2024 08:09 |
| Last Modified: | 12 Nov 2024 08:09 |
| URI: | http://repository.stfi.ac.id/id/eprint/1466 |
Actions (login required)
 |
View Item |
